Published Date: 15 Dec 2023
Improvements in 2-year PFS and OS, but not for primary refractory illness.
Read Full NewsAlmost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to participate in a clinical trial. The trial would do high-powered radiation targeted at her tumor prior ...
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. ...
Indoor hydroponic gardening—a method of growing plants using nutrient-rich water instead of soil—could help cancer patients develop better mental health, eat a healthier diet and enjoy a better overall quality of life.
In the United States, the incarcerated population is aging. About 15% of incarcerated adults, or approximately 175,000 people, are now 55 years or older.
1.
Safe and acceptable telehealth suicide prevention program.
2.
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer
3.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
4.
Renewing the call for a national Cancer Patient's Bill of Rights
5.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
1.
Breakthroughs in Oncology: Advances in Immunotherapy, Radiation & Precision Diagnostics
2.
Everything You Need to Know About the Latest Hyponatremia Algorithm
3.
Neuroendocrine Tumors: Case Study on Diagnosis, Treatment Strategies & Patient Management
4.
Breaking Down Leukocytoclastic Vasculitis: Causes, Symptoms and Treatment
5.
The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation